Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima–Media Thickness
- 1 June 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 36 (6) , 1278-1285
Abstract
Objective—: Previous studies suggested that the lectin-complement pathway plays a complex role in cardiovascular disease (CVD). To date, no prospective human studies have investigated the relationship between the initiating factor of the lectin pathway, that is, mannose-binding lectin (MBL), and low-grade inflammation, endothelial dysfunction, or carotid intima–media thickness (cIMT). Moreover, MBL-associated proteases (MASPs) and MBL-associated proteins (MAps), which mediate downstream complement activation, have not been studied in the development of CVD. Approach and Results—: In a prospective cohort (n=574; age 60±7 years; 7-year follow-up), we investigated longitudinal associations of plasma MBL, MASP-1, MASP-2, MASP-3, and MAp44 with biomarker scores that reflect low-grade inflammation and endothelial dysfunction, respectively, and with cIMT. We also investigated their associations with incident CVD (n=73). In adjusted analyses, low-grade inflammation was lowest in the middle tertile (T Middle ) of MBL, that is, T Middle was 0.19 SD (0.03 to 0.34) lower than T Low , and 0.15 SD (−0.02 to 0.31) lower than T High . cIMT was 28 μm (−50 to −5) lower in the highest MBL tertile (T High ) than in T Middle and did not differ between T Low and T Middle . MBL was not associated with endothelial dysfunction or CVD. MASP-1 and MASP-2 were not associated with any cardiovascular outcomes. MASP-3 and MAp44 were, independently of MBL levels, associated with endothelial dysfunction (per 1 SD higher MASP-3: β=0.10 SD [0.02 to 0.18]; per 1 SD higher MAp44 β=0.12 SD [0.04 to 0.20]) but not with low-grade inflammation, cIMT, or CVD. Conclusions—: High MBL may contribute to low cIMT, whereas the association of MBL with low-grade inflammation was nonlinear. MASP-1 and MASP-2 were not associated with adverse cardiovascular outcomes. MASP-3 and MAp44 may play a role in endothelial dysfunction, potentially independent of lectin-pathway activation.Keywords
This publication has 37 references indexed in Scilit:
- Mannan-Binding Lectin in Cardiovascular DiseaseBioMed Research International, 2014
- Mannose-Binding Lectin Deficiency Is Associated with Myocardial Infarction: The HUNT2 Study in NorwayPLOS ONE, 2012
- Mannose-binding lectin and the balance between immune protection and complicationExpert Review of Anti-infective Therapy, 2011
- Low mannose-binding lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic south asians. a prospective cohort studyCardiovascular Diabetology, 2011
- Mannose‐binding lectin and innate immunityImmunological Reviews, 2009
- Genetically determined high serum levels of mannose‐binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritisArthritis & Rheumatism, 2007
- Serum Levels of Mannose-Binding Lectin and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin DeficiencyJournal of Experimental Medicine, 2004
- Prospective Analysis of Mannose-Binding Lectin Genotypes and Coronary Artery Disease in American IndiansCirculation, 2004
- Association of Chlamydia pneumoniae With Coronary Artery Disease and Its Progression Is Dependent on the Modifying Effect of Mannose-Binding LectinCirculation, 2002